Overview

Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

The study is to observe the anti-HBV therapeutic effects of peginterferon alfa-2b in chronic hepatitis b patients with e antigen positive based on the detection of interferon gene mutation (IFNA2 p.Ala120Thr) and interferon receptor (IFNAR2) detection.

Phase:

Phase 4

Details

Lead Sponsor:

Third Affiliated Hospital, Sun Yat-Sen University

Treatments:

Entecavir
Interferon-alpha
Interferons
Peginterferon alfa-2b
Tenofovir